Cytokinetics (CYTK) ROE: History & Chart

Cytokinetics, Incorporated(CYTK)

Biotechnology · South San Francisco, CA

$61.88-0.82 (-1.30%)

Delayed quote: Oct 6, 2026, 11:55 AM EDT

About Cytokinetics, Incorporated

Cytokinetics, Incorporated, a biopharmaceutical company, focuses on discovering, developing, and commercializing novel muscle activators and muscle inhibitors as potential treatments for debilitating diseases in the United States. The company markets MYQORZO, a novel, oral, and small molecule cardiac myosin inhibitor for the treatment of symptomatic oHCM. It also develops Aficamten, a novel, oral, and small molecule cardiac myosin inhibitor for the treatment of HCM; and omecamtiv mecarbil, a potential treatment across the continuum of care in heart failure with severely reduced ejection fraction. In addition, the company is involved in developing and Ulacamten, a novel, selective, oral, and small molecule cardiac myosin inhibitor designed to reduce the hypercontractility associated with heart failure with preserved ejection fraction in Phase 1 clinical trials; and CK-089, a fast skeletal muscle troponin activator in Phase 1 clinical trials. Cytokinetics, Incorporated was incorporated in 1997 and is headquartered in South San Francisco, California.

South San Francisco, CA

673 employees

www.cytokinetics.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Robert I. Blum

View full financials

CYTK Return on Equity (ROE) Metrics

RETURN ON EQUITY (ROE)

N/A

RETURN ON EQUITY (ROE) AVG TTM

N/A

RETURN ON EQUITY (ROE) AVG 3Y

-340.42%

RETURN ON EQUITY (ROE) AVG 5Y

-269.99%

RETURN ON EQUITY (ROE) AVG 10Y

-93.78%

RETURN ON EQUITY (ROE) AVG 15Y

-69.48%

RETURN ON EQUITY (ROE) AVG 20Y

-56.34%

CURRENT VS TTM AVG

N/A

CURRENT VS 3Y AVG

N/A

CURRENT VS 5Y AVG

N/A

CURRENT VS 10Y AVG

N/A

CURRENT VS 15Y AVG

N/A

CURRENT VS 20Y AVG

N/A

NAME	MARKET CAP	RETURN ON EQUITY (ROE)	TTM	3Y	5Y
Cytokinetics, Incorporated (CYTK)	$7.70B	N/A	N/A	-340.42%	-269.99%
HealthEquity, Inc. (HQY)vs ›	$7.66B	11.88%	7.39%	4.04%	2.40%
Hinge Health, Inc. (HNGE)vs ›	$7.58B	31.68%	-71.21%	-55.91%	-55.91%
Praxis Precision Medicines, Inc. (PRAX)vs ›	$7.84B	-25.29%	-37.79%	-133.44%	-103.64%
Ionis Pharmaceuticals, Inc. (IONS)vs ›	$7.39B	-128.44%	-77.53%	-74.21%	-60.06%
Caris Life Sciences, Inc. (CAI)vs ›	$8.11B	17.77%	-40.95%	-11.78%	-8.64%
Alkermes plc (ALKS)vs ›	$7.08B	3.66%	19.17%	13.19%	6.34%
Oscar Health, Inc. (OSCR)vs ›	$8.41B	26.84%	-21.41%	-36.14%	-25.75%
Kymera Therapeutics, Inc. (KYMR)vs ›	$8.67B	-19.85%	-23.25%	-28.82%	-25.53%
Chemed Corporation (CHE)vs ›	$6.68B	33.11%	27.03%	27.48%	31.41%

NAME

MARKET CAP

RETURN ON EQUITY (ROE)

TTM

Cytokinetics, Incorporated (CYTK)

$7.70B

N/A

-340.42%

-269.99%

HealthEquity, Inc. (HQY)vs ›

$7.66B

11.88%

7.39%

4.04%

2.40%

Hinge Health, Inc. (HNGE)vs ›

$7.58B

31.68%

-71.21%

-55.91%

Praxis Precision Medicines, Inc. (PRAX)vs ›

$7.84B

-25.29%

-37.79%

-133.44%

-103.64%

Ionis Pharmaceuticals, Inc. (IONS)vs ›

$7.39B

-128.44%

-77.53%

-74.21%

-60.06%

Caris Life Sciences, Inc. (CAI)vs ›

$8.11B

17.77%

-40.95%

-11.78%

-8.64%

Alkermes plc (ALKS)vs ›

$7.08B

3.66%

19.17%

13.19%

6.34%

Oscar Health, Inc. (OSCR)vs ›

$8.41B

26.84%

-21.41%

-36.14%

-25.75%

Kymera Therapeutics, Inc. (KYMR)vs ›

$8.67B

-19.85%

-23.25%

-28.82%

-25.53%

Chemed Corporation (CHE)vs ›

$6.68B

33.11%

27.03%

27.48%

31.41%

Return on Equity (ROE) FAQ

What is the return on equity (ROE) for Cytokinetics, Incorporated (CYTK)?

The return on equity (ROE) for CYTK stock is N/A.

What is the 3Y average return on equity (ROE) for Cytokinetics, Incorporated (CYTK)?

The 3Y average return on equity (ROE) for CYTK stock is -340.42%.

What is the 5Y average return on equity (ROE) for Cytokinetics, Incorporated (CYTK)?

The 5Y average return on equity (ROE) for CYTK stock is -269.99%.

What is the 10Y average return on equity (ROE) for Cytokinetics, Incorporated (CYTK)?

The 10Y average return on equity (ROE) for CYTK stock is -93.78%.

What is the 15Y average return on equity (ROE) for Cytokinetics, Incorporated (CYTK)?

The 15Y average return on equity (ROE) for CYTK stock is -69.48%.

What is the 20Y average return on equity (ROE) for Cytokinetics, Incorporated (CYTK)?

The 20Y average return on equity (ROE) for CYTK stock is -56.34%.

DATE	RETURN ON EQUITY (ROE)
2024-06-30	-502.33%
2022-06-30	-193.80%
2022-03-31	-221.62%
2021-12-31	-88.29%
2021-09-30	-91.83%
2021-06-30	-944.65%
2021-03-31	-198.96%
2020-12-31	-112.27%
2020-09-30	-76.20%
2018-12-31	-409.84%
2018-09-30	-231.06%
2018-06-30	-173.80%
2018-03-31	-132.74%
2017-12-31	-116.34%
2017-09-30	-54.51%
2017-06-30	-8.25%
2017-03-31	3.19%
2016-12-31	17.44%
2016-09-30	0.08%
2016-06-30	-86.46%
2016-03-31	-70.95%
2015-12-31	-54.67%
2015-09-30	-29.46%
2015-06-30	-22.64%
2015-03-31	-17.56%
2014-12-31	-15.91%
2014-09-30	-22.49%
2014-06-30	-29.45%
2014-03-31	-34.63%
2013-12-31	-61.93%
2013-09-30	-130.07%
2013-06-30	-94.56%
2013-03-31	-73.70%
2012-12-31	-56.51%
2012-09-30	-50.61%
2012-06-30	-46.00%
2012-03-31	-109.69%
2011-12-31	-99.34%
2011-09-30	-83.88%
2011-06-30	-73.96%
2011-03-31	-81.92%
2010-12-31	-69.89%
2010-09-30	-65.95%
2010-06-30	-52.79%
2010-03-31	24.61%
2009-12-31	24.20%
2009-09-30	23.33%
2009-06-30	15.25%
2009-03-31	-112.65%
2008-12-31	-113.28%
2008-09-30	-102.56%
2008-06-30	-74.16%
2008-03-31	-58.99%
2007-12-31	-48.93%
2007-09-30	-47.11%
2007-06-30	-49.57%
2007-03-31	-46.20%
2006-12-31	-53.72%
2006-09-30	-61.05%
2006-06-30	-51.12%
2006-03-31	-44.61%
2005-12-31	-57.44%
2005-09-30	-54.96%
2005-06-30	-49.06%
2005-03-31	-42.85%
2004-12-31	-34.59%
2004-09-30	-28.34%
2004-06-30	-24.61%

DATE

RETURN ON EQUITY (ROE)

2024-06-30

-502.33%

2022-06-30

-193.80%

2022-03-31

-221.62%

2021-12-31

-88.29%

2021-09-30

-91.83%

2021-06-30

-944.65%

2021-03-31

-198.96%

2020-12-31

-112.27%

2020-09-30

-76.20%

2018-12-31

-409.84%

2018-09-30

-231.06%

2018-06-30

-173.80%

2018-03-31

-132.74%

2017-12-31

-116.34%

2017-09-30

-54.51%

2017-06-30

-8.25%

2017-03-31

3.19%

2016-12-31

17.44%

2016-09-30

0.08%

2016-06-30

-86.46%

2016-03-31

-70.95%

2015-12-31

-54.67%

2015-09-30

-29.46%

2015-06-30

-22.64%

2015-03-31

-17.56%

2014-12-31

-15.91%

2014-09-30

-22.49%

2014-06-30

-29.45%

2014-03-31

-34.63%

2013-12-31

-61.93%

2013-09-30

-130.07%

2013-06-30

-94.56%

2013-03-31

-73.70%

2012-12-31

-56.51%

2012-09-30

-50.61%

2012-06-30

-46.00%

2012-03-31

-109.69%

2011-12-31

-99.34%

2011-09-30

-83.88%

2011-06-30

-73.96%

2011-03-31

-81.92%

2010-12-31

-69.89%

2010-09-30

-65.95%

2010-06-30

-52.79%

2010-03-31

24.61%

2009-12-31

24.20%

2009-09-30

23.33%

2009-06-30

15.25%

2009-03-31

-112.65%

2008-12-31

-113.28%

2008-09-30

-102.56%

2008-06-30

-74.16%

2008-03-31

-58.99%

2007-12-31

-48.93%

2007-09-30

-47.11%

2007-06-30

-49.57%

2007-03-31

-46.20%

2006-12-31

-53.72%

2006-09-30

-61.05%

2006-06-30

-51.12%

2006-03-31

-44.61%

2005-12-31

-57.44%

2005-09-30

-54.96%

2005-06-30

-49.06%

2005-03-31

-42.85%

2004-12-31

-34.59%

2004-09-30

-28.34%

2004-06-30

-24.61%

Return on Equity (ROE): N/A

CYTK Return on Equity (ROE)

CYTK Average Return on Equity (ROE) Chart

CYTK Return on Equity (ROE) Metrics

CYTK Competitors' Return on Equity (ROE)

Return Analysis

Return on Equity (ROE) Formula & Definition

Return on Equity (ROE) FAQ

CYTK Return on Equity (ROE) History

Related Metrics